| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/31/2012 | US8106270 Soybean cultivar S090252 |
| 01/31/2012 | US8106269 Soybean cultivar S090001 |
| 01/31/2012 | US8106268 Soybean cultivar 8734242 |
| 01/31/2012 | US8106267 Soybean variety XB53T09 |
| 01/31/2012 | US8106266 Soybean variety XB31E09 |
| 01/31/2012 | US8106265 Soybean variety XB40H09 |
| 01/31/2012 | US8106264 Soybean cultivar 7828080 |
| 01/31/2012 | US8106263 Lettuce cultivar 41-0601032-B |
| 01/31/2012 | US8106262 Lettuce named DIP 6992 |
| 01/31/2012 | US8106261 Methods of producing GABA |
| 01/31/2012 | US8106260 Chimeric isoprenoid synthases and uses thereof |
| 01/31/2012 | US8106259 Compositions and methods for plant genetic modification |
| 01/31/2012 | US8106258 Generating transgenic plant; incubate tissue in low-oxygen environment, transform cells via agrobacterium, regenerate plants; tissue engineering |
| 01/31/2012 | US8106257 Expression vector comprising nucleotide sequences coding adenosylmethionine decarboxylase for use as tool in generating trees with decreased lignin content and increased wood density |
| 01/31/2012 | US8106256 Methods and means for producing hyaluronan |
| 01/31/2012 | US8106255 Targeted chromosomal mutagenasis using zinc finger nucleases |
| 01/31/2012 | US8106254 Heat- and ethylene-inducible fruit specific promoter |
| 01/31/2012 | US8106253 Transgenic brassica with improved meal quality |
| 01/31/2012 | US8106252 Use of recombinant polypeptides from a lupinus plant and nucleotide sequences encoding it as plant growth promoters, antimicrobial or insecticidal |
| 01/31/2012 | US8106251 Tissue products derived from porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 01/31/2012 | US8106226 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
| 01/31/2012 | US8106182 Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field |
| 01/31/2012 | US8106181 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 01/31/2012 | US8106180 Expression vector comprising hairpin loop for use in generating interfering RNA to treat infection and cell proliferative disorders |
| 01/31/2012 | US8106179 Small interfering RNA specific to sub-units α, α′and β of the Kinase Protein ck2, and the applications of the same |
| 01/31/2012 | US8106173 Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8 |
| 01/31/2012 | US8106171 Nel-related type 1 polypeptide |
| 01/31/2012 | US8106169 Plant production of immunoglobulins with reduced fucosylation |
| 01/31/2012 | US8106162 Artificial antibody polypeptides |
| 01/31/2012 | US8106159 Insecticidal toxin complex fusion protiens |
| 01/31/2012 | US8106156 PRO1120 polypeptides |
| 01/31/2012 | US8106153 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/31/2012 | US8106027 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106026 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106025 Method for inhibiting the activity of mir-155 |
| 01/31/2012 | US8106024 Method of treating cancer with an RPN2 gene expression inhibitor |
| 01/31/2012 | US8106010 Variants of pigment epithelium derived factor and uses thereof |
| 01/31/2012 | US8105982 Aptamers and methods for their in vitro selection and uses thereof |
| 01/31/2012 | US8105847 Nano-sized optical fluorescence labels and uses thereof |
| 01/31/2012 | US8105836 Chemical inhibitors of mismatch repair |
| 01/31/2012 | US8105831 Parvoviral production of HLA homozygous cells |
| 01/31/2012 | US8105830 Polyspecific binding molecules and uses thereof |
| 01/31/2012 | US8105828 Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals |
| 01/31/2012 | US8105827 Protein expression systems |
| 01/31/2012 | US8105825 Multiple inducible gene regulation system |
| 01/31/2012 | US8105818 Ready-to-use electroporation cuvette including frozen electrocompetent cells |
| 01/31/2012 | US8105816 Nucleic acid molecules encoding BANK1 splice variants |
| 01/31/2012 | US8105813 Materials and methods for the generation of fully 2′-modified nucleic acid transcripts |
| 01/31/2012 | US8105811 Sugar transport sequences, yeast strains having improved sugar uptake, and methods of use |
| 01/31/2012 | US8105805 High affinity human antibodies to human IL-18 receptor |
| 01/31/2012 | US8105804 Polynucleotides encoding novel PCSK9 variants |
| 01/31/2012 | US8105799 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
| 01/31/2012 | US8105789 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
| 01/31/2012 | US8105787 Applications of nucleic acid fragments |
| 01/31/2012 | US8105782 Materials and methods relating to nucleic acid amplification and profiling |
| 01/31/2012 | US8105779 Compositions and methods for detecting the presence of Cryptosporidium parvum in a test sample |
| 01/31/2012 | US8105774 Using peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PGC-1Beta) as tool to identify modulators for treatment of free radical associated disorders |
| 01/31/2012 | US8105772 DNA detection method using molecular beacon with the use of monomer emission/excimer emission switching of fluorescent molecule |
| 01/31/2012 | US8105767 Cells for detection of enteroviruses |
| 01/31/2012 | US8105610 Method of making novel erythrovirus V9 VP2 capsid polypeptides |
| 01/31/2012 | US8105609 Administering a vaccine of a nucleic acid having a transcriiptional unit (TU) to direct a host cell to to biosynthesize the matrix and envelope (M and E) protein antigens; the TU comprises a prM signal sequence and ribosomal bindng sequence; carriers; encephalitis and yellow fever |
| 01/31/2012 | US8105606 Chimeric proteins that induce effects directed against viruses |
| 01/31/2012 | US8105575 Use of internal promoters in mammalian expression vectors including plasmid vectors and enhancer-deleted retroviral vectors; producing infectious retroviral particles; delivering a polypeptide or transcript of interest encoded by the polynucleotide of interest |
| 01/31/2012 | US8105574 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 01/31/2012 | US8105573 Protease resistant modified IFN beta polypeptides and their use in treating diseases |
| 01/31/2012 | US8104533 Spray nozzle apparatus and method of use |
| 01/31/2012 | CA2524907C Polyethylene glycol/polycation block copolymers |
| 01/31/2012 | CA2520537C Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein |
| 01/31/2012 | CA2443947C Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 01/31/2012 | CA2432370C Attenuated flaviviral live vaccine comprising a capsid protein deletion |
| 01/31/2012 | CA2393575C Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 01/31/2012 | CA2392221C Bovine immunodeficiency virus (biv) based vectors |
| 01/31/2012 | CA2371658C Method for the identification and/or the quantification of a target compound |
| 01/31/2012 | CA2365780C Carriers having biological substance |
| 01/31/2012 | CA2339889C Identification of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 01/31/2012 | CA2285672C Purified telomerase |
| 01/31/2012 | CA2274989C Cloned glucagon-like peptide-2 receptors |
| 01/31/2012 | CA2233670C Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof |
| 01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/30/2012 | CA2747462A1 Systems and methods for the secretion of recombinant proteins in gram negative bacteria |
| 01/26/2012 | WO2012012741A1 FERULOYL-CoA:MONOLIGNOL TRANSFERASE |
| 01/26/2012 | WO2012012738A1 Genome editing using targeting endonucleases and single-stranded nucleic acids |
| 01/26/2012 | WO2012012716A2 Targeting micrornas for the treatment of fibrosis |
| 01/26/2012 | WO2012012698A1 FERULOYL-CoA:MONOLIGNOL TRANSFERASE |
| 01/26/2012 | WO2012012689A2 Circulating micrornas are biomarkers of various diseases |
| 01/26/2012 | WO2012012676A2 Use of mir-29 for cell protection |
| 01/26/2012 | WO2012012667A2 Methods and compositions for modification of a hla locus |
| 01/26/2012 | WO2012012605A2 Bacterial mediated delivery of nuclear protein into pluripotent and differentiated cells |
| 01/26/2012 | WO2012012531A2 Compositions and methods featuring il-6 and il-21 antagonists |
| 01/26/2012 | WO2012012480A2 Transgenic plants expressing a viral antifungal protein |
| 01/26/2012 | WO2012012462A2 Plant-based production of heterologous proteins |
| 01/26/2012 | WO2012012412A2 Glyphosate-inducible promoter its use |
| 01/26/2012 | WO2012012403A1 Corn with increased yield and nitrogen utilization efficiency |
| 01/26/2012 | WO2012011955A2 Compositions and methods for production and screening of monoclonal antibodies |
| 01/26/2012 | WO2012011778A2 Cancer diagnosis kit and pharmaceutical composition for prevention or treatment of cancer |
| 01/26/2012 | WO2012011777A2 Kit for diagnosing colorectal cancer and pharmaceutical composition for prevention or treatment of colorectal cancer |
| 01/26/2012 | WO2012011621A1 Amyloid-beta clearance |
| 01/26/2012 | WO2012011596A1 A method for producing an l- amino acid using a bacterium of the enterobacteriaceae family with enhanced expression of the bssr gene |
| 01/26/2012 | WO2012011396A1 Transgenic rice plant capable of expressing nanoantibody |
| 01/26/2012 | WO2012011114A2 Sequence specific double-stranded dna/rna binding compounds and uses thereof |